S McGregor1, Robert Hilsden, H Yang. 1. Population Health Research, Alberta Health Services Cancer Care, Calgary, Alberta. elizabeth.mcgregor@albertahealthservices.ca
Abstract
BACKGROUND: Colorectal cancer (CRC) screening is an efficacious but underused means to reduce the burden of CRC. Population-based CRC screening programs are currently being implemented in Canada and physicians are key partners in increasing screening uptake. The current study identified physician attitudes and barriers that need to be addressed by provincial programs. METHODS: A mailed survey of primary care physicians in Alberta. RESULTS: The survey response rate was 42.4% (806 of 1903). The majority of physicians suggested CRC screening as part of a routine periodic examination; however, the approach to test selection and the type of tests recommended varied by geographical region. The majority of physicians agreed (48%) or strongly agreed (36%) that a provincewide screening program is the best approach to reducing mortality from CRC. However, there were many serious concerns identified - the most common was endoscopic capacity for follow-up of patients with a positive fecal occult blood test (FOBT), which was cited by 55% to 69% of the physicians surveyed. The barriers to three commonly available tests (FOBT, flexible sigmoidoscopy and colonoscopy) varied according to health region, and the types of barriers identified varied according to the specific test. INTERPRETATION: Screening for CRC is gradually being accepted among primary care physicians in Alberta. A key finding of the present descriptive study was the regional variation in practices, perceived barriers and concerns about provincial population-based screening programs based on FOBT as the primary screening test. Provincial programs will need to address the issue of endoscopic capacity and perceived barriers to FOBT to gain primary care physician acceptance of FOBT-based CRC screening programs.
BACKGROUND:Colorectal cancer (CRC) screening is an efficacious but underused means to reduce the burden of CRC. Population-based CRC screening programs are currently being implemented in Canada and physicians are key partners in increasing screening uptake. The current study identified physician attitudes and barriers that need to be addressed by provincial programs. METHODS: A mailed survey of primary care physicians in Alberta. RESULTS: The survey response rate was 42.4% (806 of 1903). The majority of physicians suggested CRC screening as part of a routine periodic examination; however, the approach to test selection and the type of tests recommended varied by geographical region. The majority of physicians agreed (48%) or strongly agreed (36%) that a provincewide screening program is the best approach to reducing mortality from CRC. However, there were many serious concerns identified - the most common was endoscopic capacity for follow-up of patients with a positive fecal occult blood test (FOBT), which was cited by 55% to 69% of the physicians surveyed. The barriers to three commonly available tests (FOBT, flexible sigmoidoscopy and colonoscopy) varied according to health region, and the types of barriers identified varied according to the specific test. INTERPRETATION: Screening for CRC is gradually being accepted among primary care physicians in Alberta. A key finding of the present descriptive study was the regional variation in practices, perceived barriers and concerns about provincial population-based screening programs based on FOBT as the primary screening test. Provincial programs will need to address the issue of endoscopic capacity and perceived barriers to FOBT to gain primary care physician acceptance of FOBT-based CRC screening programs.
Authors: Kathryn A Phillips; Su-Ying Liang; Uri Ladabaum; Jennifer Haas; Karla Kerlikowske; David Lieberman; Robert Hiatt; Mika Nagamine; Stephanie L Van Bebber Journal: Med Care Date: 2007-02 Impact factor: 2.983
Authors: Marion R Nadel; Jean A Shapiro; Carrie N Klabunde; Laura C Seeff; Robert Uhler; Robert A Smith; David F Ransohoff Journal: Ann Intern Med Date: 2005-01-18 Impact factor: 25.391
Authors: Nancy N Baxter; Meredith A Goldwasser; Lawrence F Paszat; Refik Saskin; David R Urbach; Linda Rabeneck Journal: Ann Intern Med Date: 2008-12-15 Impact factor: 25.391
Authors: D Armstrong; A Ng Barkun; Y Chen; S Daniels; R Hollingworth; R H Hunt; D Leddin Journal: Can J Gastroenterol Date: 2008-02 Impact factor: 3.522
Authors: Nada Abdel-Malek; Anna M Chiarelli; Margaret Sloan; Donna E Stewart; Verna Mai; Roberta I Howlett Journal: Eur J Cancer Prev Date: 2008-02 Impact factor: 2.497
Authors: Shawn A Ritchie; Jon Tonita; Riaz Alvi; Denis Lehotay; Hoda Elshoni; Su- Myat; James McHattie; Dayan B Goodenowe Journal: Int J Cancer Date: 2012-06-26 Impact factor: 7.396